Canada markets closed

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
42.40-0.08 (-0.19%)
At close: 04:00PM EDT
42.40 0.00 (0.00%)
After hours: 05:16PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.59B
Enterprise Value 745.25M
Trailing P/E 34.75
Forward P/E 9.81
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.61
Price/Book (mrq)0.90
Enterprise Value/Revenue 1.22
Enterprise Value/EBITDA 9.63

Trading Information

Stock Price History

Beta (5Y Monthly) 0.61
52-Week Change 366.93%
S&P500 52-Week Change 322.36%
52 Week High 345.76
52 Week Low 324.69
50-Day Moving Average 342.13
200-Day Moving Average 339.21

Share Statistics

Avg Vol (3 month) 343.9k
Avg Vol (10 day) 321.52k
Shares Outstanding 537.58M
Implied Shares Outstanding 637.67M
Float 88.09M
% Held by Insiders 178.48%
% Held by Institutions 113.42%
Shares Short (Apr 15, 2024) 447.18k
Short Ratio (Apr 15, 2024) 41.48
Short % of Float (Apr 15, 2024) 40.58%
Short % of Shares Outstanding (Apr 15, 2024) 40.13%
Shares Short (prior month Mar 15, 2024) 458.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 28, 2018
Ex-Dividend Date 4Dec 10, 2018
Last Split Factor 22:1
Last Split Date 3Jul 27, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 7.48%
Operating Margin (ttm)10.69%

Management Effectiveness

Return on Assets (ttm)1.03%
Return on Equity (ttm)2.61%

Income Statement

Revenue (ttm)610.83M
Revenue Per Share (ttm)16.25
Quarterly Revenue Growth (yoy)12.90%
Gross Profit (ttm)N/A
EBITDA 68.88M
Net Income Avi to Common (ttm)45.7M
Diluted EPS (ttm)1.22
Quarterly Earnings Growth (yoy)178.20%

Balance Sheet

Total Cash (mrq)902.22M
Total Cash Per Share (mrq)24
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.60
Book Value Per Share (mrq)47.33

Cash Flow Statement

Operating Cash Flow (ttm)142.87M
Levered Free Cash Flow (ttm)81.01M